HAVcR-1 is overexpressed in prostate cancer and, therefore, the staining of prostate biopsies could be used to aid in prostate cancer diagnosis; however, it would be of interest to investigate whether there is any correlation between the total HAVcR-1 expression and disease prognosis, as this would have more clinical benefit. This evidence concerns the gene HAVCR1 and Familial prostate cancer.